vs
Side-by-side financial comparison of Integer Holdings Corp (ITGR) and MASIMO CORP (MASI). Click either name above to swap in a different company.
Integer Holdings Corp is a global medical device contract manufacturing partner for leading healthcare and medtech enterprises. It designs, develops and produces high-precision components, assemblies and finished medical devices across core segments including cardiac care, neuromodulation, orthopedics and portable medical products, serving markets across North America, Europe and Asia-Pacific.
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $371.5M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $372.0M | ||
| Q4 24 | — | $600.7M | ||
| Q3 24 | — | $504.6M | ||
| Q2 24 | — | $496.3M | ||
| Q1 24 | — | $492.8M | ||
| Q4 23 | — | $548.9M |
| Q3 25 | — | $-100.4M | ||
| Q2 25 | — | $51.3M | ||
| Q1 25 | — | $-170.7M | ||
| Q4 24 | — | $-349.6M | ||
| Q3 24 | — | $9.8M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $18.9M | ||
| Q4 23 | — | $33.9M |
| Q3 25 | — | 62.1% | ||
| Q2 25 | — | 62.9% | ||
| Q1 25 | — | 62.9% | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | 52.2% | ||
| Q2 24 | — | 51.3% | ||
| Q1 24 | — | 49.0% | ||
| Q4 23 | — | 47.9% |
| Q3 25 | — | 22.5% | ||
| Q2 25 | — | 17.4% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | -59.8% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 6.9% | ||
| Q4 23 | — | 8.0% |
| Q3 25 | — | -27.0% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | -45.9% | ||
| Q4 24 | — | -58.2% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 3.8% | ||
| Q4 23 | — | 6.2% |
| Q3 25 | — | $-1.84 | ||
| Q2 25 | — | $0.94 | ||
| Q1 25 | — | $-3.12 | ||
| Q4 24 | — | $-6.54 | ||
| Q3 24 | — | $0.18 | ||
| Q2 24 | — | $0.29 | ||
| Q1 24 | — | $0.35 | ||
| Q4 23 | — | $0.63 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
